Drugs - Special Access to Drugs and Health Products
The Special Access Programme (SAP) provides access to nonmarketed drugs for practitioners treating patients with serious or life-threatening conditions when conventional therapies have failed, are unsuitable, or unavailable. The SAP authorizes a manufacturer to sell a drug that cannot otherwise be sold or distributed in Canada.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2020-05-05
Data overview
- Formats
- HTML
- File languages
- English, French